Lite Strategy, Inc. Legal Fees
Lite Strategy, Inc. (LITS) reported Legal Fees of $283.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-05-13
- Lite Strategy, Inc. legal fees for the quarter ending 2026-03-31 was $283.00K, a 14.50% decline year-over-year.
- Lite Strategy, Inc. legal fees for the quarter ending 2025-12-31 was $560.00K, a 21.90% decline year-over-year.
- Lite Strategy, Inc. legal fees for the quarter ending 2025-03-31 was $331.00K.
- Lite Strategy, Inc. legal fees for the quarter ending 2024-12-31 was $717.00K.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month |
|---|---|---|---|
| 2026-03-31 | $283.00K 10-Q · filed 2026-05-13 | $843.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.29M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $560.00K 10-Q · filed 2026-02-17 | $1.01M 10-Q · filed 2026-02-17 | |
| 2025-03-31 | $331.00K 10-Q · filed 2026-05-13 | $1.05M derived: sum of 2 quarters · filed 2026-05-13 | $1.52M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $717.00K 10-Q · filed 2026-02-17 | $1.19M 10-Q · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |